miR-223 as a therapeutic target for enhancing MDSC suppressive activities
Nov. 10, 2022
Researchers from Washington University presented data from a study that aimed to identify myeloid-derived suppressor cell (MDSC) markers in patients with multiple sclerosis (MS).